In summary, we demonstrated that Girdin could regulate the glycolysis of HCC cells via the PI3K/AKT/HIF-1α signaling pathway, which affects the sensitivity of tumor cells to radiotherapy. This evidence concerns the gene HIF1A and hepatocellular carcinoma.